БЛОГ

Archive for the ‘biotech/medical’ category: Page 43

Sep 30, 2024

An Ultrathin Graphene Brain Implant Was Just Tested in a Person

Posted by in categories: biotech/medical, computing, neuroscience

A Spanish biotech company sees the carbon material as a way to power the brain-computer interfaces of the future.

Sep 30, 2024

MIT scientists use a new type of nanoparticle to make vaccines more powerful

Posted by in categories: biotech/medical, nanotechnology

Many vaccines, including vaccines for hepatitis B and whooping cough, consist of fragments of viral or bacterial proteins.


“Not only are we delivering the protein in a more controlled way through a nanoparticle, but the compositional structure of this particle is also acting as an adjuvant,” Jaklenec says. “We were able to achieve very specific responses to the Covid protein, and with a dose-sparing effect compared to using the protein by itself to vaccinate.”

Vaccine access

Continue reading “MIT scientists use a new type of nanoparticle to make vaccines more powerful” »

Sep 30, 2024

Beyond The Code: Human Factors In Robotic Surgery Risk Management

Posted by in categories: biotech/medical, robotics/AI

A key aspect of human factors in robotic surgery is the training and proficiency of the surgeon. Robotic systems, although designed to enhance precision, rely heavily on the expertise of the individuals operating them. Companies should invest in comprehensive training programs that extend beyond basic certification and promote a culture of continuous learning and skill development.

Simulation-based training, for example, provides a risk-free environment for practicing complex procedures, helping surgeons build confidence and proficiency. Implementing standardized certification processes ensures consistent competency levels among surgeons.

Sep 30, 2024

DOOM can now run on a quantum computer with Quandoom port — seminal FPS blood and gore mixed with spooky action

Posted by in categories: biotech/medical, computing, quantum physics

DOOM has been ported to quantum computers, marking another milestone for this seminal 3D gaming title. However, the coder behind this feat admits that there is currently no quantum computer capable of executing (playing) this code right now. All is not lost, though, as Quandoom can run on a classical computer, even a modest laptop, using a lightweight QASM simulator.

Barcelona ICFO-based Quantum Information PhD student Luke Mortimer, AKA Lumorti, is behind this newest port of DOOM. In the ReadMe file accompanying the Quandoom 1.0.0 release, Lumorti quips that “It is a well-known fact that all useful computational devices ever created are capable of running DOOM,” and humorously suggests that Quandoom may be the first practical use found for quantum computers.

Sep 30, 2024

How Your Brain Detects Patterns without Conscious Thought

Posted by in categories: biotech/medical, neuroscience

To make sense of the world around us, the brain must process an…


Neurons in certain brain areas integrate ‘what’ and ‘when’ information to discern hidden order in events happening in real time.

By Miryam Naddaf & Nature magazine

Continue reading “How Your Brain Detects Patterns without Conscious Thought” »

Sep 30, 2024

Gene Therapy Is Developing Rapidly in the Asia Pacific

Posted by in category: biotech/medical

New deadlier viruses?


This article discusses the journeys of three gene therapy startups in South Korea, Japan, and China, and the products they are developing.

Sep 30, 2024

Woman, 25, ‘cured’ of type 1 diabetes after stem cell transplant in world first

Posted by in category: biotech/medical

SCIENTISTS claim to have reversed a woman’s type 1 diabetes with a pioneering stem cell transplant.

The 25-year-old had suffered from the chronic condition for more than a decade.

Sep 30, 2024

Spinning artificial spider silk into next-generation medical materials

Posted by in categories: bioengineering, biotech/medical, education, genetics

Spider silk is one of the strongest materials on Earth, technically stronger than steel for a material of its size. However, it’s tough to obtain—spiders are too territorial (and cannibalistic) to breed them like silkworms, leading scientists to turn to artificial options.

Teaching microbes to produce the through is one such option, but this has proved challenging because the proteins tend to stick together, reducing the silk’s yield. So, Bingbing Gao and colleagues wanted to modify the natural protein sequence to design an easily spinnable, yet still stable, spider silk using microbes.

The team first used these microbes to produce the silk proteins, adding extra peptides as well. The new peptides, following a pattern found in the protein sequence of amyloid polypeptides, helped the artificial silk proteins form an orderly structure when folded and prevented them from sticking together in solution, increasing their yield.

Sep 30, 2024

New filtration material could remove long-lasting chemicals from water

Posted by in categories: biotech/medical, chemistry, engineering

Water contamination by the chemicals used in today’s technology is a rapidly growing problem globally. A recent study by the U.S. Centers for Disease Control found that 98 percent of people tested had detectable levels of PFAS, a family of particularly long-lasting compounds also known as “forever chemicals,” in their bloodstream.

A new filtration material developed by researchers at MIT might provide a nature-based solution to this stubborn contamination issue. The material, based on natural silk and cellulose, can remove a wide variety of these persistent chemicals as well as heavy metals. And, its antimicrobial properties can help keep the filters from fouling.

The findings are described in the journal ACS Nano, in a paper by MIT postdoc Yilin Zhang, professor of civil and environmental engineering Benedetto Marelli, and four others from MIT.

Sep 29, 2024

Overcoming Treatment Challenges in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapy

Posted by in category: biotech/medical

Immunotherapies are the cornerstone of treatment for multiple myeloma (MM), demonstrating clinically meaningful improvements in response rates and progression-free survival (PFS) through the use of more precise, targeted therapies.


Experts discuss immunotherapy advancements and challenges of resistance, efficacy, and toxicity in patient management.

Page 43 of 2,738First4041424344454647Last